Deep Dive: How Eli Lilly Became the First $1 Trillion Healthcare Company
The Rundown
00:00
GLP-1s beyond weight loss
Zaid highlights emerging indications like sleep apnea, fatty liver, and heart failure that could expand markets.
Play episode from 07:53
Transcript
